Citations 5
Efficacy and Safety of Ravulizumab in Adults With Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Interim Analysis From the Ongoing Phase 3 CHAMPION-NMOSD Trial (S38.007)
Bennett, Jeffrey L. , Guevara, Celia Oreja, Palace, Jacqueline , Allen, Kerstin , Parks, Becky , Kim, Ho Jin , Palace, Jacqueline , Bennett, Jeffrey L , Palace, Jacqueline , Pittock, Sean J. , Barnett, Michael , Berthele, Achim , Seze, Jerome De , Levy, Michael, Nakashima, Ichiro , Paul, Friedemann , Pozzilli, Carlo
Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available
Long-term efficacy and safety of eculizumab monotherapy in AQP4+ neuromyelitis optica spectrum disorder (1578)
Kim, Ho Jin , Guevara, Celia Oreja, Shang, Shulian, Yountz, Marcus, Miller, Larisa , Armstrong, Róisín, Wingerchuk, Dean M. , Pittock, Sean J. , Fujihara, Kazuo , Palace, Jacqueline , Berthele, Achim , Nakashima, Ichiro , Levy, Michael
Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available
Pharmacokinetics and Pharmacodynamics of Ravulizumab in Adults with Anti-Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder During the Phase 3 CHAMPION-NMOSD trial (S5.004)
Ortiz, Stephan , Guevara, Celia Oreja, Kim, Ho Jin , Levy, Michael , Levy, Michael , Pittock, Sean J. , Berthele, Achim , Levy, Michael, Nakashima, Ichiro
Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available
Efficacy subgroup analyses from the phase 3 CHAMPION-NMOSD trial in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (S5.003)
Bennett, Jeffrey L. , Guevara, Celia Oreja, Palace, Jacqueline , Allen, Kerstin , Mashhoon, Yasmin, Yountz, Marcus, Kim, Ho Jin , Levy, Michael , Bennett, Jeffrey L , Levy, Michael , Palace, Jacqueline , Levy, Michael, Pittock, Sean J. , Barnett, Michael , Berthele, Achim , Seze, Jerome De , Nakashima, Ichiro , Paul, Friedemann , Pozzilli, Carlo
Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available
Efficacy and safety of ravulizumab in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: outcomes from the phase 3 CHAMPION-NMOSD trial (S5.002)
Bennett, Jeffrey L. , Guevara, Celia Oreja, Palace, Jacqueline , Allen, Kerstin , Mashhoon, Yasmin, Yountz, Marcus, Levy, Michael , Bennett, Jeffrey L , Levy, Michael , Palace, Jacqueline , Pittock, Sean J. , Barnett, Michael , Berthele, Achim , Seze, Jerome De , Levy, Michael, Nakashima, Ichiro , Paul, Friedemann , Pozzilli, Carlo , Kim, Ho Jin
Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available